XML 56 R41.htm IDEA: XBRL DOCUMENT v3.26.1
FAIR VALUE MEASUREMENTS (Tables)
3 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
Schedule of Financial Assets and Liabilities Measured on Recurring Basis
The following tables present information on the financial assets and liabilities measured and recorded at fair value on a recurring basis as of March 31, 2026 and December 31, 2025.
Financial Assets and Liabilities Measured at Fair Value on a
Recurring Basis as of March 31, 2026 Using
Fair value as of March 31, 2026
Quoted prices in active markets
for identical assets
 (Level 1)
Other observable inputs
 (Level 2)
Significant unobservable inputs
 (Level 3)
Assets:
Securities and other investments owned:
Equity securities$485,612 $455,157 $— $30,455 
Partnership interests and other investments52,650 — — 52,650 
Corporate bonds33,134 — 33,134 — 
Other fixed income securities2,081 1,570 511 — 
Total securities and other investments owned573,477 456,727 33,645 83,105 
Loans receivable, at fair value24,927 — — 24,927 
Total assets measured at fair value$598,404 $456,727 $33,645 $108,032 
Liabilities:
Securities sold not yet purchased:
Equity securities$14,154 $14,154 $— $— 
Corporate bonds639 — 639 — 
Other fixed income securities2,040 1,994 46 — 
Total securities sold not yet purchased16,833 16,148 685 — 
Liability-classified warrants11,080 — — 11,080 
Total liabilities measured at fair value$27,913 $16,148 $685 $11,080 
Financial Assets and Liabilities Measured at Fair Value on a
Recurring Basis at December 31, 2025 Using
Fair value at December 31, 2025
Quoted prices in active markets
for identical assets
 (Level 1)
Other observable inputs
 (Level 2)
Significant unobservable inputs
 (Level 3)
Assets:
Securities and other investments owned:
Equity securities$304,422 $233,199 $— $71,223 
Partnership interests and other investments40,082 — — 40,082 
Corporate bonds31,751 — 31,751 — 
Other fixed income securities4,373 2,957 1,416 — 
Total securities and other investments owned380,628 236,156 33,167 111,305 
Loans receivable, at fair value26,303 — — 26,303 
Total assets measured at fair value$406,931 $236,156 $33,167 $137,608 
Liabilities:
Securities sold not yet purchased:
Equity securities$9,342 $9,342 $— $— 
Corporate bonds467 — 467 — 
Other fixed income securities— — — — 
Total securities sold not yet purchased9,809 9,342 467 — 
Contingent consideration6,400 — — 6,400 
Total liabilities measured at fair value$16,209 $9,342 $467 $6,400 
Schedule of Fair Value Measurement Inputs and Valuation Techniques
The following tables summarize the significant unobservable inputs in the fair value measurement of Level 3 financial assets and liabilities by category of investment and valuation technique as of March 31, 2026 and December 31, 2025:
Fair value at March 31,
2026
Valuation
Technique
Unobservable
Input
Range
Weighted
Average(1)
Assets:
Equity securities$27,898 Market approachMultiple of sales
0.7x - 6.0x
2.3x
Market price of related security
$10.24 - $12.01
$10.80
1,718 Monte Carlo simulationAnnualized volatility
130.0%
130.0%
839 Option pricing modelAnnualized volatility
47.0% - 93.0%
54.0%
Partnership interests and other investments52,650 Market approachDiscount rate
—% - 3.7%
0.5%
Market price of related security
$526.59
$526.59
Loans receivable at fair value24,927 Discounted cash flowDiscount rate
6.8% - 56.5%
16.7%
Total level 3 assets measured at fair value$108,032 
Liabilities:
Liability-classified warrants$11,080 Monte Carlo simulation and Black-Scholes option pricing modelAnnualized volatility87.5%87.5%
Total level 3 liabilities measured at fair value$11,080 
(1) Unobservable inputs were weighted by the relative fair value of the financial instruments.
Fair value at December 31,
2025
Valuation TechniqueUnobservable InputRange
Weighted
Average(1)
Assets:
Equity securities$25,572 Market approachMultiple of sales
0.7x - 6.0x
2.3x
Market price of related security
$2.14 - $12.01
$10.97
43,101Monte Carlo simulationAnnualized volatility
120.0% - 148.0%
121.0%
2,550 Option pricing modelAnnualized volatility
46.0% - 115.0%
57.0%
Partnership interests and other investments40,082Market approachDiscount rate
—% - 3.5%
0.5%
Market price of related security
$421.00
$421.00
Loans receivable at fair value24,468 Discounted cash flowDiscount rate
6.8% - 56.5%
21.0%
1,835 Market approachMarket price of related security
$8.56
$8.56
Total Level 3 assets measured at fair value$137,608 
Liabilities:
Liability-classified warrants$6,400 Monte Carlo simulation and Black-Scholes option pricing modelAnnualized volatility
85.0%
85.0%
Discount for lack of marketability
14.7%
14.7%
Total Level 3 liabilities measured at fair value$6,400 
(1) Unobservable inputs were weighted by the relative fair value of the financial instruments.
The following table presents the carrying amounts of equity securities valued under the measurement alternative that were still held as of the balance sheet date for which a nonrecurring fair value measurement was recorded during the period:
Fair ValueLevel 2Level 3
As of March 31, 2026
Non-marketable equity securities measured using the measurement alternative$11,493 $11,493 $— 
As of December 31, 2025
Non-marketable equity securities measured using the measurement alternative$13,867 $13,739 $128 
Schedule of Fair Value Measurement of Level 3 Financial Assets and Liabilities
The changes in Level 3 fair value hierarchy during the three months ended March 31, 2026 and 2025 were as follows:
Equity SecuritiesPartnership Interests And Other InvestmentsLoans Receivable at Fair ValueContingent ConsiderationLiability-Classified WarrantsEmbedded Derivatives
Three Months Ended March 31, 2026
Level 3 balance at beginning of year$71,223 $40,082 $26,303 $— $6,400 $— 
Fair value adjustments(1)
(2,049)— 6,545 — 4,680 — 
Relating to undistributed earnings— 12,568 484 — — — 
Purchases/originations150,002 — 20,100 — — — 
Sales— — — — — — 
Settlements/repayments(188,721)— (28,505)— — — 
Transfers in and/or out of Level 3— — — — — — 
Level 3 balance at end of period$30,455 $52,650 $24,927 $— $11,080 $— 
Change in unrealized gains (losses)(2)
$924 $— $(145)$— $(4,680)$— 
Three Months Ended March 31, 2025
Level 3 balance at beginning of year$40,516 $— $90,103 $4,538 $— $— 
Fair value adjustments(3)
(3,844)— (8,096)103 (2,700)3,349 
Relating to undistributed earnings— — — — — — 
Purchases/originations869 — 58,008 — 7,860 11,244 
Sales(10,000)— (6,840)— — — 
Settlements/repayments(11)— (34,579)(48)— — 
Transfers in and/or out of Level 3— — — — — — 
Level 3 balance at end of period$27,530 $— $98,596 $4,593 $5,160 $14,593 
Change in unrealized gains (losses)(2)
$(3,844)$— $(9,738)$(103)$2,700 $(3,349)
(1)
Fair value adjustments during the three months ended March 31, 2026 include the following: $(2,049) of realized and unrealized gains (losses) on equity securities is comprised of $(925) included in “Trading gains (losses), net” and $(1,124) of “Realized and unrealized gains (losses) on investments”, $6,545 of fair value adjustments on loans included in “Fair value adjustments on loans”, and $(4,680) of unrealized losses related to liability-classified warrants included in “Change in fair value of financial instruments and other” line items in the accompanying unaudited condensed consolidated statements of operations.
(2)
For the three months ended March 31, 2026 and 2025, the change in unrealized gains (losses) is related to financial instruments held at the end of each respective reporting period.
(3)
Fair value adjustments during the three months ended March 31, 2025 include the following: $(3,844) of realized and unrealized gains (losses) on equity securities comprised of $(1,082) included in “Trading gains (losses), net” and $(2,762) included in “Realized and unrealized gains (losses) on investments”, $(8,096) of fair value adjustments on loans included in “Fair value adjustments on loans”, $(103) of realized and unrealized losses related to contingent consideration included in “Selling, general and administrative expenses”, $2,700 of unrealized gains related to liability-classified warrants included in “Change in fair value of financial instruments and other”, and $(3,349) of unrealized losses related to embedded derivatives included in “Change in fair value of financial instruments and other” line items in the accompanying unaudited condensed consolidated statements of operations.
Schedule of Fair Value, by Balance Sheet Grouping
March 31, 2026December 31, 2025
Fair Value Hierarchy LevelCarrying AmountFair ValueCarrying AmountFair Value
Revolving credit facilityLevel 2$10,708 $10,695 $6,638 $6,638 
Term loans, netLevel 2$116,673 $116,991 $119,297 $120,931 
Senior notes payableLevel 2$903,474 $677,528 $1,033,782 $681,890 
New Notes payableLevel 3$268,016 $170,228 $268,016 $166,796